Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
94.28
+1.12 (1.20%)
Dec 5, 2025, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Zimmer Biomet Holdings stock have an average target of 108.56, with a low estimate of 88 and a high estimate of 140. The average target predicts an increase of 15.15% from the current stock price of 94.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Zimmer Biomet Holdings stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 7 | 7 | 7 | 6 | 5 | 5 |
| Hold | 10 | 9 | 7 | 8 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 21 | 20 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $101 → $93 | Hold | Maintains | $101 → $93 | -1.36% | Nov 10, 2025 |
| UBS | UBS | Strong Sell Maintains $96 → $88 | Strong Sell | Maintains | $96 → $88 | -6.66% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $111 → $101 | Buy | Maintains | $111 → $101 | +7.13% | Nov 6, 2025 |
| Barclays | Barclays | Sell Maintains $105 → $104 | Sell | Maintains | $105 → $104 | +10.31% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $115 → $100 | Buy → Hold | Downgrades | $115 → $100 | +6.07% | Nov 6, 2025 |
Financial Forecast
Revenue This Year
8.31B
from 7.68B
Increased by 8.20%
Revenue Next Year
8.80B
from 8.31B
Increased by 5.92%
EPS This Year
8.24
from 4.43
Increased by 85.93%
EPS Next Year
8.65
from 8.24
Increased by 5.02%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.7B | 9.4B | ||||
| Avg | 8.3B | 8.8B | ||||
| Low | 8.0B | 8.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.1% | 12.7% | ||||
| Avg | 8.2% | 5.9% | ||||
| Low | 4.6% | 0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.65 | 9.52 | ||||
| Avg | 8.24 | 8.65 | ||||
| Low | 7.77 | 8.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 95.4% | 15.6% | ||||
| Avg | 85.9% | 5.0% | ||||
| Low | 75.4% | -1.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.